The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Long-term Exercise and Atherogenic Activity of Blood Mononuclear Cells in Persons at Risk of Developing Ischemic Heart Disease
Abstract
CONTEXT: Increasing evidence demonstrates that atherosclerosis is an immunologically mediated disease in which the secretion of atherogenic and atheroprotective cytokines, by infiltrating blood mononuclear cells, plays an important role. It is not known whether long-term exercise alters this atherogenic and atheroprotective activity directly. OBJECTIVE: To determine the effect of long-term exercise on the atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. DESIGN: Before-after trial using a 6-month individualized, supervised exercise program, with an enrollment period from December 1996 to October 1997. SETTING: Hospital-based community wellness center. PARTICIPANTS: Of 110 persons who responded to a public request for volunteers, 52 met the inclusion criteria (risk ratio for myocardial infarction > or =1.7 based on serum complement and/or C-reactive protein levels, and normal exercise treadmill test results). Forty-three of the 52 enrollees (25 women [mean age, 49.7 years] and 18 men [mean age, 48.1 years]) completed the study; 9 withdrew for personal reasons. Additional risk factors for ischemic heart disease included hypercholesterolemia (65.1 %), a family history of coronary heart disease (62.8%), inactivity (60.5%), hypertension (32.6%), obesity (25.6%), smoking (11.6%), and diabetes mellitus (4.7%). MAIN OUTCOME MEASURES: Blood levels were compared at baseline and after the exercise program had been completed for the following: spontaneous and phytohemagglutinin-induced production of interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma (atherogenic cytokines), and interleukin 4, interleukin 10, and transforming growth factor beta 1 (atheroprotective cytokines) by blood mononuclear cells; lymphocyte phenotypes and mitogenic responses to phytohemagglutinin; and serum C-reactive protein levels. RESULTS: Subjects exercised for a mean of 2.5 (range, 0.3-7.4) hours per week. Mononuclear cell production of atherogenic cytokines fell by 58.3 % (P<.001) following the exercise program, where as the production of atheroprotective cytokines rose by 35.9% (P<.001). Changes in transforming growth factor beta 1 and in phytohemagglutinin-induced atherogenic cytokine production after the exercise program were proportionate to the time subjects spent performing repetitive lower-body motion exercises (P<.02), indicating a dose-response relationship. After the exercise program, changes in cellular function were reflected systemically by a 35% decrease in serum levels of C-reactive protein (P=.12). CONCLUSIONS: Our data suggest that long-term exercise decreases the atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. This may be a mechanism whereby physical activity protects against ischemic heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Physical Fitness and All-Cause Mortality: A Prospective Study of Healthy Men and Women
Blair, S. N. (1989) · JAMA · doi:10.1001/jama.1989.03430170057028 · Cited by 2,658
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
PHYSICAL ACTIVITY AS AN INDEX OF HEART ATTACK RISK IN COLLEGE ALUMNI1
PAFFENBARGER, R. S., WING, A. L., & HYDE, R. T. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112608 · Cited by 1,980
Blair, S. N. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540030039029 · Cited by 1,819
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Physical Fitness and All-Cause Mortality
Macintyre, J. (1995) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-199510000-00015 · Cited by 898
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Physical Activity, Fitness, and Health
(2012) · Fitness & Health · doi:10.5040/9781718209107.part-001 · Cited by 739
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
Munro, J. M., & Cotran, R. S. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_10 · Cited by 698
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
Libby, P., & Hansson, G. K. (1991) · PubMed · Cited by 663
Relationship of Leisure-Time Physical Activity and Mortality: The Finnish Twin Cohort
Kujala, U. M., Kaprio, J., Sarna, S., & Koskenvuo, M. (1998) · JAMA · doi:10.1001/jama.279.6.440 · Cited by 605
Mayer-Davis, E. J. (1998) · JAMA · doi:10.1001/jama.279.9.669 · Cited by 601
Effects of Walking on Mortality among Nonsmoking Retired Men
Hakim, A. A., Petrovitch, H., Burchfiel, C. M., Ross, G. W., Rodriguez, B. L., White, L. R., Yano, K., Curb, J. D., & Abbott, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380204 · Cited by 560
te Velde, A., Huijbens, R., Heije, K., de Vries, J., & Figdor, C. (1990) · Blood · doi:10.1182/blood.v76.7.1392.1392 · Cited by 449
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Is atherosclerosis an immunologically mediated disease?
Wick, G., Schett, G., Amberger, A., Kleindienst, R., & Xu, Q. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80067-0 · Cited by 398
Exercise Intensity and Longevity in Men: The Harvard Alumni Health Study
Lee, I.-M. (1995) · JAMA · doi:10.1001/jama.1995.03520390039030 · Cited by 387
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old).
Kuo, C. C., Grayston, J. T., Campbell, L. A., Goo, Y. A., Wissler, R. W., & Benditt, E. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6911 · Cited by 373
Physical Activity and Mortality in Postmenopausal Women
Kushi, L. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540400037028 · Cited by 328
HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSIS
Adam, E., Probtsfield, J. L., Burek, J., Mccollum, C. H., Melnick, J. L., Petrie, B. L., Bailey, K. R., & Debakey, M. E. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90888-9 · Cited by 290
van der Wal, A. C., Das, P. K., Berg, D., van der Loos, C. M., & Becker, A. E. (1989) · PubMed · Cited by 251
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
(1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370524 · Cited by 230
Evidence for Success of Exercise in Weight Loss and Control
Blair, S. N. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00015 · Cited by 202
Atherosclerosis, autoimmunity, and vascular‐associated lymphoid tissue
Wick, G., Romen, M., Amberger, A., Metzler, B., Mayr, M., Falkensammer, G., & Xu, Q. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367355 · Cited by 197
Association of serum C3 levels with the risk of myocardial infarction
Muscari, A., Bozzoli, C., Puddu, G. M., Sangiorgi, Z., Dormi, A., Rovinetti, C., Descovich, G. C., & Puddu, P. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80314-3 · Cited by 183
Immunological responses to oxidized LDL
Hörkkö, S., Binder, C. J., Shaw, P. X., Chang, M.-K., Silverman, G., Palinski, W., & Witztum, J. L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00333-6 · Cited by 172
Borish, L., & Rosenwasser, L. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80146-1 · Cited by 159
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes
Fenton, M. J., Buras, J. A., & Donnelly, R. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1283 · Cited by 142
Takami, S., Yamashita, S., Kihara, S., Ishigami, M., Takemura, K., Kume, N., Kita, T., & Matsuzawa, Y. (1998) · Circulation · doi:10.1161/01.cir.97.8.721 · Cited by 126
IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells
Krakauer, T. (1995) · Immunology Letters · doi:10.1016/0165-2478(94)00226-h · Cited by 109
Reckless, J., Metcalfe, J. C., & Grainger, D. J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1542 · Cited by 100
Inflammatory and immunological nature of atherosclerosis
Watanabe, T., Haraoka, S., & Shimokama, T. (1996) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)88773-0 · Cited by 75
DOWN‐REGULATION OF FIBRINOGEN BIOSYNTHESIS BY IL‐4, IL‐10 AND IL‐13
Vasse, M., Paysant, J., Soria, J., Mirshahi, S., Vannier, J., & Soria, C. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1731.x · Cited by 63
Altered plasma levels of cytokines in patients with ischemic heart disease
Tashiro, H., Shimokawa, H., Yamamoto, K., Momohara, M., Tada, H., & Takeshita, A. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199703000-00004 · Cited by 57
Immunological mechanisms in atherosclerosis
Yokota, T., & Hansson, G. K. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01229.x · Cited by 57
Physical activity, lipid and lipoprotein metabolism, and lipid transport.
Stefanick, M. L., Wood, P. D., Bouchard, C., Shephard, R. J., & Stephens, T. W. (1994) · Cited by 38
Immunological response to oxidized LDL
Witztum, J. L. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06116-9 · Cited by 37
Inhibition of human monocyte adhesion by interleukin-4
Elliott, M., Gamble, J. R., Park, L., Vadas, M., & Lopez, A. F. (1991) · Blood · doi:10.1182/blood.v77.12.2739.2739 · Cited by 36
Inflammatory and immunological nature of atherosclerosis
Watanabe, T., Haraoka, S., & Shimokama, T. (1996) · International Journal of Cardiology · doi:10.1016/0167-5273(96)02635-6 · Cited by 32
Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
Anglés‐Cano, E. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997001100002 · Cited by 21
Transforming growth factor beta is sequestered into an inactive pool by lipoproteins
Grainger, D. J., Byrne, C. D., Witchell, C., & Metcalfe, J. C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34948-8 · Cited by 20
Atherogenesis and Ischemic Heart Disease
Selwyn, A. P., Kinlay, S., & Ganz, P. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00813-8 · Cited by 18
Mortality patterns -- preliminary data, United States, 1996.
(1997) · PubMed · Cited by 12
Blair, S. N. (1995) · JAMA · doi:10.1001/jama.1995.03520380029031 · Cited by 3
Cited by
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers
Kasapis, C., & Thompson, P. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.077 · Cited by 1,149
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Effect of exercise training on endothelium‐derived nitric oxide function in humans
Green, D. J., Maiorana, A., O'Driscoll, G., & Taylor, R. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.068197 · Cited by 1,040
Metadata
- Authors
- Smith, J. K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-05-12
- Volume
- 281
- Issue
- 18
- Pages
- 1722
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2155071621
- Cited by
- 424
- References
- 50
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.